Segment Information (Tables)

3 Months Ended

Mar. 31, 2014

Revenues, Cost Of Services And Products, And Gross Margins For Operating Segments


	Three Months Ended
	March 31,
	2014		2013
Revenues:
Medical devices	$	19,455	$	19,796
Preservation services		16,276		15,677
Othera		--		63
Total revenues		35,731		35,536

Cost of products and preservation services:
Medical devices		3,801		3,465
Preservation services		9,457		8,795
Total cost of products and preservation services		13,258		12,260

Gross margin:
Medical devices		15,654		16,331
Preservation services		6,819		6,882
Othera		--		63
Total gross margin	$	22,473	$	23,276

Summary Of Net Revenues By Product


	Three Months Ended
	March 31,
	2014		2013
Products:
BioGlue and BioFoam	$	15,240	$	15,464
PerClot		916		864
Revascularization technologies		1,684		2,191
HeRO Graft		1,615		1,277
Total products		19,455		19,796

Preservation services:
Cardiac tissue		7,190		6,645
Vascular tissue		9,086		9,032
Total preservation services		16,276		15,677

Othera		--		63
Total revenues	$	35,731	$	35,536

___________________

aThe “Other” designation includes grant revenue.

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details